Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safflower Extract and Aceglutamide Injection for Acute Ischemic Stroke (Phase 4, double-blind, randomized, placebo-controlled)
ChiCTR2000040968Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Guhong injection with Placebo (Guhong simulant) (2 arms). Primary endpoint: Effectiveness (primary efficacy outcome). Started Dec 2020; status: recruiting.
02
Drugs
Guhong Injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000040968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040968.